Vorinostat Suspended Phase 1 Trials for Tumors of the Central Nervous System Treatment

IndicationsStatusPurposePhase
SuspendedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03050450Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors